Texas Original Compassionate Cultivation released results from its clinical evaluation of the company’s post-traumatic stress disorder focus group. Focus group participants sampled TXOG’s gummy, lozenge and tincture products at various dosages based on individual prescriptions from their physicians.
Following the focus group’s completion, TXOG released survey results in which patients reported quick onset of the products’ medicinal effects and unanimous relief from their PTSD symptoms. In addition to the survey, Dr. Matthew Brimberry, a board-certified family medicine physician, the head of Texas Cannabis Clinic and the focus group’s presiding physician, evaluated the group using an entrance and exit PCL-5 questionnaire, a 20-item self-reporting measure that assesses the 20 clinical symptoms of PTSD listed in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders.
